Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd - Laporan Laba Rugi (TTM)

Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd
CN ˙ SZSE
CN¥ 29.72 ↓ -0.25 (-0.83%)
2025-09-12
BAHAGING PRESYO
Laporan Laba Rugi (TTM)

Laporan Laba Rugi Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2022
01-01
2022
03-31
2022
06-30
2022
09-30
2023
01-01
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 626 670 764 834 842 887 911 917 958 974 1,001 1,043 997 981 965 936 982 974 1,014 1,093
Change (%) 7.06 13.98 9.18 0.90 5.44 2.70 0.60 4.51 1.67 2.75 4.22 -4.43 -1.63 -1.58 -3.02 4.84 -0.78 4.12 7.75
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 224 256 296 333 335 370 386 397 415 408 437 446 417 414 379 359 388 382 417 491
Change (%) 14.25 15.89 12.49 0.65 10.46 4.23 2.82 4.62 -1.69 7.01 2.06 -6.40 -0.85 -8.29 -5.46 8.29 -1.74 9.26 17.83
% of Revenue 35.72 38.12 38.76 39.94 39.84 41.73 42.35 43.29 43.34 41.90 43.64 42.73 41.85 42.18 39.31 38.32 39.58 39.20 41.14 44.99
Gross Operating Profit 402 415 468 501 506 517 525 520 543 566 564 597 580 567 586 577 593 592 597 601
Change (%) 3.06 12.80 7.08 1.07 2.12 1.60 -1.03 4.42 4.24 -0.32 5.90 -2.96 -2.19 3.31 -1.44 2.70 -0.15 0.80 0.70
% of Revenue 64.28 61.88 61.24 60.06 60.16 58.27 57.65 56.71 56.66 58.10 56.36 57.27 58.15 57.82 60.69 61.68 60.42 60.80 58.86 55.01
SG&A 296 309 348 377 388 391 399 388 404 424 425 451 442 423 439 436 448 439 436 440
Change (%) 4.46 12.39 8.43 2.86 0.80 2.12 -2.73 4.01 5.15 0.10 6.10 -1.89 -4.34 3.81 -0.67 2.72 -2.11 -0.54 0.92
% of Revenue 47.29 46.14 45.49 45.18 46.06 44.03 43.78 42.33 42.13 43.57 42.44 43.21 44.36 43.14 45.50 46.60 45.66 45.05 43.03 40.31
R&D 12 13 13 13 14 14 14 15 17 18 19 25 25 20 21 24 28 38 38 39
Change (%) 4.26 2.97 -2.61 9.50 -1.51 2.78 2.57 16.79 5.58 6.80 27.01 0.34 -18.38 2.16 15.46 18.70 32.35 2.46 1.74
% of Revenue 1.99 1.94 1.75 1.56 1.69 1.58 1.58 1.61 1.80 1.87 1.95 2.37 2.49 2.07 2.14 2.55 2.89 3.85 3.79 3.58
OpEx 539 585 665 731 745 784 808 808 845 861 891 931 890 868 850 829 873 867 902 985
Change (%) 8.48 13.75 9.90 1.88 5.29 3.05 -0.00 4.55 1.90 3.43 4.50 -4.34 -2.55 -2.06 -2.49 5.40 -0.70 3.96 9.26
% of Revenue 86.11 87.26 87.09 87.67 88.52 88.39 88.69 88.15 88.19 88.39 88.97 89.21 89.30 88.47 88.04 88.52 88.99 89.06 88.92 90.17
Operating Income 87 85 99 103 97 103 103 109 113 113 110 113 107 113 115 108 108 107 112 107
Change (%) -1.78 15.49 4.32 -6.05 6.63 0.02 5.38 4.19 -0.07 -2.39 1.96 -5.24 6.04 2.11 -6.92 0.53 -1.43 5.43 -4.37
% of Revenue 13.89 12.74 12.91 12.33 11.48 11.61 11.31 11.85 11.81 11.61 11.03 10.79 10.70 11.53 11.96 11.48 11.01 10.94 11.08 9.83
Interest Expense -2 -3 -4 -4 -5 -3 -3 -8 -10 -14 -15 -11 -9 -6 -5 -4 -4 -2 -1 -1
Change (%) 62.40 44.19 7.37 8.93 -27.27 -11.73 160.58 27.26 36.04 9.58 -29.38 -20.40 -28.71 -22.58 -14.93 -9.34 -57.22 -5.02 -7.67
% of Revenue -0.28 -0.43 -0.54 -0.53 -0.57 -0.39 -0.34 -0.88 -1.07 -1.43 -1.52 -1.03 -0.86 -0.62 -0.49 -0.43 -0.37 -0.16 -0.15 -0.13
Net Income 80 79 87 89 86 93 96 96 98 101 103 111 107 110 120 116 116 120 120 121
Change (%) -0.79 9.99 2.39 -3.24 8.08 2.51 0.11 2.52 3.20 1.46 7.70 -2.94 2.92 8.68 -3.49 0.06 3.77 0.08 0.32
% of Revenue 12.74 11.80 11.39 10.68 10.24 10.50 10.48 10.43 10.23 10.38 10.25 10.60 10.76 11.26 12.43 12.37 11.81 12.35 11.87 11.05

Source: Capital IQ

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista